B70/100

Is DaVita (DVA) a risky stock?

Sector: Health Care Price: $235.78 Composite: 70/100

As of July 21, 2026, Clavix grades DaVita (DVA) B for risk, a composite score of 70 out of 100 on an A+ to F scale, which puts DVA in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.

Grade as of July 21, 2026. Clavix regrades every trading day.

The five risk dimensions behind DVA's grade

Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how DVA scores on each, as of July 21, 2026.

Financial healthbalance sheet, margins, cash flow
47
News sentimentscored, sourced recent coverage
64
Macro exposuresensitivity to rates, dollar, oil
65
Sector resiliencestrength vs the broad market
81
Price stabilitydrawdown and volatility
56

What's moving DVA's risk right now

Company-specific signals Clavix flags behind DVA's current grade, drawn from recent news and filings as of July 21, 2026.

Regulatory · supporting the grade

DaVita avoids a large-scale, class-wide labor lawsuit over meal break practices, removing a significant potential wage-and-hour liability that could have resulted in substantial b…

Earnings & results · mixed signal

Earnings are roughly in line with expectations, providing little catalyst in either direction.

What a B grade means

On the Clavix A+ to F scale, DVA's composite of 70 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.

A+AA-B+BB-C+CC-D+DD-F
Get Clavix on iPhone → Or grade your whole portfolio free, no account needed.

This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell DVA or any security. Grades are risk indicators, not predictions of return. Data may be delayed.